Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07074912 · ClinicalTrials.gov registry record · NA

Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department

A NA study of Fever, sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
440
Enrollment target
1
Study location

NCT07074912 is a NA study of Fever that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 440 participants, below the 575-participant average among 18 other Fever trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07074912, a NA study of Fever, is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
440 participants
Enrollment target
1
Study location

Study Summary

The study aims to evaluate whether unscheduled return visits within one week for similar complaints are impacted by ensuring parents leave the emergency department (ED) with a prescription for appropriately dosed acetaminophen and ibuprofen for their child.

Conditions Studied

Interventions

  • OTHER Prescription for weight-based dosing of antipyretic
  • OTHER Standard discharge instructions

Study Locations (1)

Texas

  • Dell Children's Medical Center - Austin

Trial Details

FieldValue
Enrollment Target 440 participants
Start Date 2024-12-15
Est. Completion 2026-03-15
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT07074912

The ClinicalTrials.gov registry entry for NCT07074912 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 575-participant average among 18 other Fever trials with a reported enrollment target (23% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fever appearing as the primary indexed condition, and to 2 interventions - of which Prescription for weight-based dosing of antipyretic is the first listed.

NCT07074912 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07074912 about?

NCT07074912 is a clinical study titled "Prescription Antipyretics to Decrease Unscheduled Return Visits In A Pediatric Emergency Department". The study aims to evaluate whether unscheduled return visits within one week for similar complaints are impacted by ensuring parents leave the emergency department (ED) with a prescription for appropriately dosed acetaminophen and ibuprofen for their child.

What is the current status of trial NCT07074912?

This trial is currently recruiting. It is a NA study. The enrollment target is 440 participants. The study started on 2024-12-15. Estimated completion is 2026-03-15.

What conditions does trial NCT07074912 study?

This clinical trial studies the following conditions: Fever.

What interventions are being tested in trial NCT07074912?

The interventions under investigation include: Prescription for weight-based dosing of antipyretic (OTHER), Standard discharge instructions (OTHER).

Who is sponsoring clinical trial NCT07074912?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07074912 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fever

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.